PAM
ONC

Panagora Asset Management’s BeOne Medicines Ltd ONC Stock Holding History

Panagora Asset Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.1M Buy
59,831
+2,511
+4% +$740K 0.05% 267
2026
Q1 		$17M Buy
57,320
+24,379
+74% +$7.89M 0.06% 255
2025
Q4 		$10M Buy
32,941
+31,676
+2,504% +$10.4M 0.04% 294
2025
Q3 		$431K Buy
1,265
+11
+0.9% +$3.34K ﹤0.01% 841
2025
Q2 		$304K Buy
1,254
+21
+2% +$5.15K ﹤0.01% 930
2025
Q1 		$336K Buy
+1,233
New +$288K ﹤0.01% 908
2024
Q4 		– Sell
-13,454
Closed -$3.02M – 1274
2024
Q3 		$3.02M Buy
13,454
+12,029
+844% +$2.16M 0.01% 450
2024
Q2 		$203K Hold
1,425
– – ﹤0.01% 1134
2024
Q1 		$223K Hold
1,425
– – ﹤0.01% 1136
2023
Q4 		$257K Hold
1,425
– – ﹤0.01% 1118
2023
Q3 		$256K Hold
1,425
– – ﹤0.01% 1100
2023
Q2 		$254K Hold
1,425
– – ﹤0.01% 1131
2023
Q1 		$307K Hold
1,425
– – ﹤0.01% 1251
2022
Q4 		$313K Sell
1,425
-1,723
-55% -$316K ﹤0.01% 1273
2022
Q3 		$424K Buy
3,148
+451
+17% +$77.5K ﹤0.01% 1190
2022
Q2 		$437K Sell
2,697
-2,498
-48% -$390K ﹤0.01% 1200
2022
Q1 		$980K Buy
5,195
+183
+4% +$38.9K 0.01% 947
2021
Q4 		$1.36M Hold
5,012
– – 0.01% 792
2021
Q3 		$1.82M Buy
5,012
+68
+1% +$22.2K 0.01% 716
2021
Q2 		$1.7M Buy
4,944
+370
+8% +$123K 0.01% 767
2021
Q1 		$1.59M Buy
4,574
+2,556
+127% +$846K 0.01% 829
2020
Q4 		$521K Sell
2,018
-5,521
-73% -$1.52M ﹤0.01% 1212
2020
Q3 		$2.16M Sell
7,539
-7,528
-50% -$1.77M 0.01% 608
2020
Q2 		$2.84M Buy
15,067
+2,225
+17% +$362K 0.02% 554
2020
Q1 		$1.58M Sell
12,842
-6,435
-33% -$1.01M 0.01% 680
2019
Q4 		$3.19M Hold
19,277
– – 0.01% 630
2019
Q3 		$2.36M Hold
19,277
– – 0.01% 681
2019
Q2 		$2.39M Buy
19,277
+3,762
+24% +$477K 0.01% 744
2019
Q1 		$2.05M Buy
+15,515
New +$2.09M 0.01% 820

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Panagora Asset Management's ONC Position: Q2 2026 in Review

Panagora Asset Management increased its BeOne Medicines Ltd (ONC) stake by 4.4% in Q2 2026, buying an estimated $740K and bringing the position to 59,831 shares worth $17.1M. The position accounts for 0.05% of the portfolio, ranked #267.

Panagora Asset Management first reported a position in ONC in Q1 2019 and has held it in 29 quarters since. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Panagora Asset Management held 59,831 shares of BeOne Medicines Ltd worth $17.1M as of Q2 2026.
  • Panagora Asset Management bought 2,511 BeOne Medicines Ltd shares in Q2 2026, an estimated $740K.
  • BeOne Medicines Ltd made up 0.05% of Panagora Asset Management's portfolio in Q2 2026, its #267 holding.
  • Panagora Asset Management first reported a position in BeOne Medicines Ltd in Q1 2019 and has held it in 29 quarters since.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.